DFC
MRNA icon

DB Fitzpatrick & Co’s Moderna MRNA Stock Holding History

DB Fitzpatrick & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-85
Closed -$2.51K – 110
2025
Q4 		$2.51K Sell
85
-15
-15% -$408 ﹤0.01% 80
2025
Q3 		$2.58K Buy
100
+50
+100% +$1.4K ﹤0.01% 82
2025
Q2 		$1.38K Hold
50
– – ﹤0.01% 90
2025
Q1 		$1.42K Buy
+50
New +$1.77K ﹤0.01% 87
2024
Q1 		– Sell
-6
Closed -$597 – 92
2023
Q4 		$597 Sell
6
-14
-70% -$1.18K ﹤0.01% 75
2023
Q3 		$2.07K Buy
+20
New +$2.23K ﹤0.01% 68

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DB Fitzpatrick & Co's MRNA Position: Q1 2026 in Review

DB Fitzpatrick & Co sold out of Moderna (MRNA) in Q1 2026, closing a stake of 85 shares — an estimated $2.51K sold.

DB Fitzpatrick & Co first reported a position in MRNA in Q3 2023 and held it in 6 quarters. The position peaked at $2.58K in Q3 2025. 725 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • DB Fitzpatrick & Co reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • DB Fitzpatrick & Co sold 85 Moderna shares in Q1 2026, an estimated $2.51K.
  • DB Fitzpatrick & Co first reported a position in Moderna in Q3 2023 and held it in 6 quarters.
  • DB Fitzpatrick & Co's Moderna position peaked at $2.58K in Q3 2025.
  • 725 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on DB Fitzpatrick & Co's 13F filing for Q1 2026, filed 27 Apr 2026.